1. Home
  2. LMAT vs MSDL Comparison

LMAT vs MSDL Comparison

Compare LMAT & MSDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • MSDL
  • Stock Information
  • Founded
  • LMAT 1983
  • MSDL 2019
  • Country
  • LMAT United States
  • MSDL United States
  • Employees
  • LMAT N/A
  • MSDL N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • MSDL
  • Sector
  • LMAT Health Care
  • MSDL
  • Exchange
  • LMAT Nasdaq
  • MSDL NYSE
  • Market Cap
  • LMAT 1.9B
  • MSDL 1.7B
  • IPO Year
  • LMAT 2006
  • MSDL N/A
  • Fundamental
  • Price
  • LMAT $81.78
  • MSDL $19.34
  • Analyst Decision
  • LMAT Buy
  • MSDL Hold
  • Analyst Count
  • LMAT 6
  • MSDL 5
  • Target Price
  • LMAT $100.80
  • MSDL $20.00
  • AVG Volume (30 Days)
  • LMAT 174.9K
  • MSDL 355.5K
  • Earning Date
  • LMAT 07-31-2025
  • MSDL 01-01-0001
  • Dividend Yield
  • LMAT 0.98%
  • MSDL 10.34%
  • EPS Growth
  • LMAT 30.45
  • MSDL N/A
  • EPS
  • LMAT 1.97
  • MSDL N/A
  • Revenue
  • LMAT $226,256,000.00
  • MSDL N/A
  • Revenue This Year
  • LMAT $13.88
  • MSDL $1,597.39
  • Revenue Next Year
  • LMAT $8.81
  • MSDL $15.10
  • P/E Ratio
  • LMAT $41.52
  • MSDL N/A
  • Revenue Growth
  • LMAT 13.19
  • MSDL N/A
  • 52 Week Low
  • LMAT $71.42
  • MSDL $17.59
  • 52 Week High
  • LMAT $109.58
  • MSDL $24.18
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 47.11
  • MSDL 46.26
  • Support Level
  • LMAT $80.04
  • MSDL $19.13
  • Resistance Level
  • LMAT $83.15
  • MSDL $19.55
  • Average True Range (ATR)
  • LMAT 1.93
  • MSDL 0.25
  • MACD
  • LMAT -0.01
  • MSDL -0.03
  • Stochastic Oscillator
  • LMAT 42.70
  • MSDL 35.00

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About MSDL MORGAN STANLEY DIRECT LENDING FUND

Morgan Stanley Direct Lending Fund is a fund whose investment objective is to achieve attractive risk-adjusted returns via current income and to a lesser extent, capital appreciation by investing predominantly in directly originated senior secured term loans issued by U.S. middle-market companies backed by private equity sponsors. It invests predominantly in directly originated senior secured term loans including first lien senior secured term loans including unitranche loans and second lien senior secured term loans, with the balance of the investments expected to be in higher-yielding assets such as mezzanine debt, unsecured debt, equity investments and other opportunistic asset purchases.

Share on Social Networks: